Incidence and risk factors of parenteral nutrition-associated liver disease in newborn infants

Pediatrics International

Volumn 54, Issue 3, 2012, Pages 434-436

  Koseesirikul, Photchanaphorn ^a   Chotinaruemol, Somporn ^a   Ukarapol, Nuthapong ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

cholestasis; incidence; newborn; parenteral nutrition; risk factor

Indexed keywords

BILIRUBIN;

APGAR SCORE; ARTICLE; BILIRUBIN BLOOD LEVEL; BIRTH WEIGHT; CALORIC INTAKE; CARBOHYDRATE INTAKE; CHOLESTASIS; CLINICAL ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DIET RESTRICTION; EARLY DIAGNOSIS; FAT INTAKE; FEMALE; GASTROINTESTINAL SURGERY; GESTATIONAL AGE; HUMAN; INCIDENCE; JAUNDICE; LIVER DISEASE; LIVER FUNCTION TEST; MALE; MEDICAL HISTORY; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN DISEASE; NEWBORN INTENSIVE CARE; ONSET AGE; PARENTERAL NUTRITION; PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN INTAKE; RISK FACTOR; SEPSIS; STARVATION; TREATMENT DURATION;

COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; LIVER DISEASES; MALE; PARENTERAL NUTRITION; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84861637155     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2012.03627.x     Document Type: Article

References (13)

1. Ukarapol N,. Update on parenteral nutrition-associated liver disease: Pathogenesis and management. Curr. Nutr. Food Sci. 2005; 1: 161-5.
2. Beath SV, Davies P, Papadopoulou A, et al,. Parenteral nutrition-related cholestasis in postsurgical neonates: Multivariate analysis of risk factors. J. Pediatr. Surg. 1996; 31: 604-6.
3. Kubota A, Yonekura T, Hoki M, et al,. Total parenteral nutrition-associated intrahepatic cholestasis in infants: 25 years' experience. J. Pediatr. Surg. 2000; 35: 1049-51.
4. Moss RL, Das JB, Raffensperger JG, et al,. Total parenteral nutrition-associated cholestasis: Clinical and histologic correlation. J. Pediatr. Surg. 1993; 28: 1270-75.
5. Christensen RD, Henry E, Wiedmeier SE, Burnett J, Lambert DK,. Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease. J. Perinatol. 2007; 27: 284-90.
6. Weinberger B, Watorek K, Strauss R, et al,. Association of lipid peroxidation with hepatocellular injury in preterm infants. Crit. Care 2002; 6: 521-5.
7. Zambrano E, El-Hennawy M, Ehrenkranz RA, et al,. Total parenteral nutrition induced liver pathology: An autopsy series of 24 newborns cases. Pediatr. Dev. Pathol. 2004; 7: 425-32.
8. Messing B, Colombel JF, Heresbach D, et al,. Chronic cholestasis and macronutrient excess in patients treated with prolonged parenteral nutrition. Nutrition 1992; 8: 30-36.
9. Wagner WH, Lowry AC, Siberman H,. Similar liver function abnormalities occur in patients receiving glucose-based and lipid-based parenteral nutrition. Am. J. Gastroenterol. 1983; 78: 199-202.
10. Gura KM, Duggan CP, Collier SB, et al,. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: Implications for future management. Pediatrics 2006; 118: e197-201.
11. Gura KM, Lee S, Valim C, et al,. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008; 121: e678-86.
12. Diamond IR, Sterescu A, Pencharz PB, Kim JH, Wales PW,. Changing the paradigm: Omegaven for the treatment of liver failure in pediatric short bowel syndrome. J. Pediatr. Gastroenterol. Nutr. 2009; 48: 209-15.
13. Lilja HE, Finkel Y, Paulsson M, Lucas S,. Prevention and reversal of intestinal failure-associated liver disease in premature infants with short bowel syndrome using intravenous fish oil in combination with omega-6/9 lipid emulsions. J. Pediatr. Surg. 2011; 46: 1361-7.